<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health / Medical research / Pharmacovigilance / European Medicines Agency / EudraLex / European Directive on Traditional Herbal Medicinal Products / Postmarketing surveillance / Adverse effect / Qualified Person Responsible For Pharmacovigilance / EudraVigilance
Date: 2015-11-08 06:14:30
Pharmaceuticals policy
Health
Medical research
Pharmacovigilance
European Medicines Agency
EudraLex
European Directive on Traditional Herbal Medicinal Products
Postmarketing surveillance
Adverse effect
Qualified Person Responsible For Pharmacovigilance
EudraVigilance

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

Add to Reading List

Source URL: www.myereport.eu

Download Document from Source Website

File Size: 386,06 KB

Share Document on Facebook

Similar Documents

1 AugustElectronic Application Forms are now fully available for use For initial marketing authorisation (human and veterinary), variation and renewal applications

1 AugustElectronic Application Forms are now fully available for use For initial marketing authorisation (human and veterinary), variation and renewal applications

DocID: 1riM4 - View Document

eAF Question and Answers - update-KM_CPh-KP

eAF Question and Answers - update-KM_CPh-KP

DocID: 1r12d - View Document

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

DocID: 1qVx6 - View Document

COMMISSION OF THE EUROPEAN COMMUNITIES  Brussels, 10 December 2008 SECVolume I

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

CMDh IP meeting November 2015 eSubmission Karin Gröndahl Head of Registration and Information Management, MPA, Sweden

CMDh IP meeting November 2015 eSubmission Karin Gröndahl Head of Registration and Information Management, MPA, Sweden

DocID: 1qFf7 - View Document